John A. Stalfort III - 22 Jun 2023 Form 3 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
Director
Signature
/s/ Kamran Alam, Attorney-in-Fact
Issuer symbol
TSHA
Transactions as of
22 Jun 2023
Transactions value $
$0
Form type
3
Filing time
26 Jun 2023, 16:46:42 UTC
Previous filing
07 Jun 2023
Next filing
16 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TSHA Common Stock 610K 22 Jun 2023 Direct
holding TSHA Common Stock 495K 22 Jun 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as of October 25, 2018.

Remarks:

No securities beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney